Leptin, peroxisome proliferator-activated receptor-γ, and CCAAT/enhancer binding protein-α mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 2, 2000, Pages 443-449

  Krempler, Franz ^a   Breban, David ^b   Oberkofler, Hannes ^b   Esterbauer, Harald ^b   Hell, Emanuel ^a   Paulweber, Bernhard ^b   Patsch, Wolfgang ^b  

^a Krankenhaus Hallein   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiovascular risk; CCAAT; Enhancer binding protein ; Leptin; Obesity; Peroxisome proliferator activated receptor

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; RISK FACTOR;

EID: 0033960706     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.2.443     Document Type: Article

References (52)

1. Manson JE, Willet WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
2. Mc Ginnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207-2212.
3. Spiegelman BM, Flier JS. Adipogenesis: rounding out the big picture. Cell. 1996;87:377-389.
4. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
5. Chen H, Charlat O, Tartaglia LA, Woolf EA, Wenig X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell. 1996;84:491-495.
6. Lin FT, Lane MD. CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA. 1994;91:8757-8761.
7. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 1994; 79:1147-1156.
8. He Y, Chen H, Quon MJ, Reitman M. The mouse obese gene: genomic organization, promotor activity, and activation by CCAAT/enhancer-binding protein α. J Biol Chem. 1995;270:28887-28891.
9. Hwang C-S, Mandrup S, MacDougald OA, Geiman DE, Lane MD. Transcriptional activation of the mouse obese (ob) gene by CCAAT/ enhancer binding protein α. Proc Natl Acad Sci USA. 1996;93:873-877.
10. Mason MM, He Y, Chen H, Quon MJ, Reitman M. Regulation of leptin promotor function by Sp1. C/EBP, and a novel factor. Endocrinology. 1998;139:1013-1022.
11. Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE, Tontonoz P, Sariaf P, Spiegelman BM, Lowell BB. Functional antagonism between CCAAT/enhancer binding protein-α and peroxisome proliferator-activated receptor-γ on the leptin promoter. J Biol Chem. 1997;272: 5283-5290.
12. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
13. Kaplan N. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149: 1514-1520.
14. 2 is a ligand for the adipocyte determination factor PPARγ. Cell. 1995;83:803-812.
15. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisley GB, Boble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci U S A. 1997;94:4318-4323.
16. Hemati N, Ross SE, Erickson RL, Groblewski GE, MacDougald OA. Signaling pathways through which insulin regulates CCART/enhancer binding protein α (C/EBPα) phosphorylation and gene expression in 3T3-L1 adipocytes. J Biol Chem. 1997;272:25913-25919.
17. MacDougald OA, Cornelius P, Lin F-T, Chen SS, Lane MD. Glucocorticoids reciprocally regulate expression of the CCAAT/enhancer-binding protein alpha and delta genes in 3T3-L1 adipocytes and white adipose tissue. J Biol Chem. 1994;269:19041-19047.
18. Björntorp P. "Portal" adipose tissue as a generator of risk factor for cardio-vascular disease and diabetes. Arteriosclerosis. 1990;10:493-496.
19. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest. 1991;88:609-613.
20. Wahrenberg H, Lönnqvist F, Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest. 1989;84: 458-467.
21. Bounder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes. 1983;32:117-123.
22. Oberkofler H, Beer A, Breban D, Hell E, Krempler F, Patsch W. Human obese gene expression: alternative splicing of mRNA and relation to adipose tissue localization. Obes Surg. 1997;7:390-396.
23. Krempler F, Hell E, Winkler C, Breban D, Patsch W. Plasma leptin levels: interaction of obesity with a common variant of insulin receptor substrate-1. Arterioscler Thromb Vasc Biol. 1998;18:1686-1690.
24. Duncan MH, Singh BM, Wise PH, Carter G, Allaghband-Zadeh JA. A simple measure of insulin resistance. Lancet. 1995;346:120-121.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in serum, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
26. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
27. Neter J, Kutner CJ, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Methods. Chicago, 111: Irwin Inc; 1996.
28. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lalone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155-1161.
29. Considine RV, Sinha MK, Heiman ML, Kriaciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med. 1996;334:292-295.
30. Holub M, Zwiauer K, Winkler C, Dillinger-Paller B, Schuller E, Patsch W, Strobl W. Relation of plasma leptin to lipoproteins in overweight children undergoing weight reduction. Int J Obes Relat Metab Disord. 1999;23:60-66.
31. Klein S, Coppack SW, Mohamedali V, Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes. 1996;45: 984-987.
32. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest. 1997; 100:2777-2782.
33. Shimabukuro M, Loyama K, Chen G, Wang M-Y, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A. 1997;94: 4637-4641.
34. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ. 1996;313:965-969.
35. Larsson H, Elmståhl S, Ahrén B. Plasma leptin levels correlate to islet function independently of body fat in women. Diabetes. 1996;45: 1580-1584.
36. Eckel RH. Insulin resistance: an adaptation for weight maintenance. Lancet. 1992;340:1452-1453.
37. D'Adamo M, Buongiorno A, Maroccia E, Leonetti F, Barbetti F, Giaccari A, Zorretta D, Tamburrano G, Sbraccia P. Increased ob gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia. Diabetes. 1998;47:1625-1629.
38. Prins JB, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Colch). 1997;92:3-11.
39. Fried SK, Kral JG. Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int J Obes. 1986;11:129-140.
40. Elbrecht A, Chen Y, Cullinan C, Hayes N, Leibowitz MD, Moler D, Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptor γ1 and γ2. Biochem Biophys Res Commun. 1996;224:431-437.
41. Fajas L, Fruchart JC, Auwerx J. PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter. FEBS Lett. 1998;438:55-60.
42. Lefebvre A-M, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H. Depot specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998;47:98-103.
43. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, Werman A, Pories W, Caro JF, Flier JS. Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest. 1997;99:2416-2422.
44. Fajas L, Fruchart JC, Auwerx J. Transcriptional control of adipogenesis. Curr Opin Cell Biol. 1998;10:165-173.
45. Hemati N, Erickson RL, Ross SE, Liu R, MacDougald OA. Regulation of CCAAT/enhancer binding protein alpha (C/EBP alpha) gene expression by thiazolidinediones in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 1998;244:20-25.
46. Clarke SL, Robinson CE, Gimble JM. CAAT/enhancer binding protein directly modulates transcription from the peroxisome proliferator-activated receptor gamma 2 promoter. Biochem Biophys Res Commun. 1997; 240:99-103.
47. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression. Diabetes. 1997;46:342-347.
48. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P. A genetic polymorphism of the peroxisome proliferator-activated receptor 7 gene influences plasma leptin levels in obese humans. Hum Mol Genet. 1998;7:435-440.
49. Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA. Leptin regulation of peroxisome proliferator-activated receptor-γ, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun. 1998;246:660-667.
50. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell. 1997;89:331-340.
51. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963;1:785-789.
52. Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T. Troglitazone increases the number of small adipocytes without changes of white adipocyte mass in obese Zucker rats. J Clin Invest. 1998;101: 1354-1361.